Abstract:AIM:To investigate the long-term outcome of recipients and donors of adult-to-adult living-donor liver transplantation (AALDLT) for acute liver failure (ALF).METHODS:Between January 2005 and March 2010, 170 living donor liver transplantations were performed at West China Hospital of Sichuan University. All living liver donor was voluntary and provided informed consent. Twenty ALF patients underwent AALDLT for rapid deterioration of liver function. ALF was defined based on the criteria of the American Association for the Study of Liver Diseases, including evidence of coagulation abnormality [international normalized ratio (INR) ≥ 1.5] and degree of mental alteration without pre-existing cirrhosis and with an illness of < 26 wk duration. We reviewed the clinical indications, operative procedure and prognosis of AALDTL performed on patients with ALF and corresponding living donors. The potential factors of recipient with ALF and corresponding donor outcome were respectively investigated using multivariate analysis. Survival rates after operation were analyzed using the Kaplan-Meier method. Receiver operator characteristic (ROC) curve analysis was undertaken to identify the threshold of potential risk factors.RESULTS:The causes of ALF were hepatitis B (n = 18), drug-induced (n = 1) and indeterminate (n = 1). The score of the model for end-stage liver disease was 37.1 ± 8.6, and the waiting duration of recipients was 5 ± 4 d. The graft types included right lobe (n = 17) and dual graft (n = 3). The mean graft weight was 623.3 ± 111.3 g, which corresponded to graft-to-recipient weight ratio of 0.95% ± 0.14%. The segment Vor VIII hepatic vein was reconstructed in 11 right-lobe grafts. The 1-year and 3-year recipient's survival and graft survival rates were 65% (13 of 20). Postoperative results of total bilirubin, INR and creatinine showed obvious improvements in the survived patients. However, the creatinine level of the deaths was increased postoperatively and became more aggravated compared with the level of the survived recipients. Multivariate analysis showed that waiting duration was independently correlated with increased mortality (P = 0.014). Furthermore, ROC curve revealed the cut-off value of waiting time was 5 d (P = 0.011, area under the curve = 0.791) for determining the mortality. The short-term creatinine level with different recipient's waiting duration was described. The recipients with waiting duration ≥ 5 d showed the worse renal function and higher mortality than those with waiting duration < 5 d (66.7% vs 9.1%, P = 0.017). In addition, all donors had no residual morbidity. Furthermore, univariate analysis did not show that short assessment time induced the high morbidity (P = 0.573).CONCLUSION:Timely AALDLT for patients with ALF greatly improves the recipient survival. However, further systemic review is needed to investigate the optimal treatment strategy for ALF.

Efficacy of liver transplantation for acute hepatic failure: a single-center experience

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Efficacy of different therapeutic modalities for patients with acute-on-chronic liver failure induced by hepatitis B

Artificial Liver Support System Combined With Liver Transplantation In The Treatment Of Patients With Acute-On-Chronic Liver Failure

Liver Transplantation in Acute-on-chronic Liver Failure Patients with High Model for End-Stage Liver Disease (MELD) Scores: a Single Center Experience of 100 Consecutive Cases.

A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure

Liver Transplantation for Acute Hepatic Failure:A Report of 21 Cases

Treatment of Hepatic Failure with Artificial Liver Support System.

Assessment of the Combined Effect of Plasma Exchange and Plasma Perfusion on Patients with Severe Hepatitis Awaiting Orthotopic Liver Transplantation

Severe Hepatitis Treated with an Artificial Liver Support System

A Retrospective Analysis of Liver Transplantation in Treating Endstage Autoimmune Liver Disease

Effect of Artificial Liver Support System on Patients with Severe Viral Hepatitis: A Study of Four Hundred Cases

[Therapeutic Effect of Liver Transplantation on Acute Liver Failure].

A Single-Center Experience of Non-Bioartificial Liver Support Systems among Chinese Patients with Liver Failure

A Single Institution Experience with Living Donor Liver Transplantation for Acute-on-chronic Hepatitis B Liver Failure.

Artificial Liver Support and Liver Transplantation for the Treatment of Severe Hepatitis

Living Donor Auxiliary Partial Orthotopic Liver Transplantation for Acute Liver Failure: A Case Report.

[Effect of Artificial Liver Support System on the Survival Rate of High Risk Patients after Liver Transplantation].

Auxiliary partial liver transplantation for acute liver failure using "high risk" grafts: Case report

Analysis of Clinical Data and Survival Rates of 82 Patients with Acute Liver Failure

Adult-to-adult Living Donor Liver Transplantation for Acute Liver Failure in China